A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology

Volumn 44, Issue 6, 2001, Pages 940-947

  Duvic, Madeleine ^{a,b,c,d,e,f,g,h,i,j}   Olsen, Elise A ^{a,b,c,d,e,f,g,h,i,j}   Omura, George A ^{a,b,c,d,e,f,g,h,i,j}   Maize, John C ^{a,b,c,d,e,f,g,h,i,j}   Vonderheid, Eric C ^{a,b,c,d,e,f,g,h,i,j}   Elmets, Craig A ^{a,b,c,d,e,f,g,h,i,j}   Shupack, Jerome L ^{a,b,c,d,e,f,g,h,i,j}   Demierre, Marie France ^{a,b,c,d,e,f,g,h,i,j}   Kuzel, Timothy M ^{a,b,c,d,e,f,g,h,i,j}   Sanders, Deborah Y ^{a,b,c,d,e,f,g,h,i,j}  

^a UNIVERSITY OF TEXAS   (United States)

^b DUKE UNIVERSITY   (United States)

^c BIOCRYST PHARMACEUTICALS INC   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g NEW YORK UNIVERSITY   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j Dermatopathology Services   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PELDESINE; PLACEBO; PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN LYMPHOMA; T CELL LYMPHOMA; TREATMENT OUTCOME;

EID: 17844394417     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.113478     Document Type: Article

References (14)

1. Mycosis fungoides and Sézary syndrome
2. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome)
3. Mycosis fungoides and the Sézary syndrome: A review of pathogenesis, diagnosis, and therapy
4. Mycosis fungoides. Ergebnisse einer helioklimatherapie im hochgebirge (Davos, 1560 m)
5. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity
6. Purine nucleoside phosphorylase deficiency
7. BCX-34: Purine nucleoside phosphorylase (PNP) inhibitor
8. In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BC X-34: The role of GTP and dGTP
9. A dermatopharmacokinetics of topical BCX-34 cream in human skin
10. The natural history of initially untreated low-grade non-Hodgkin's lymphomas
11. Regressing cutaneous lymphomas of T-cell and B-cell lineage
12. Mycosis fungoides with spontaneously regressing CD30-positive tumorous lesions
13. Spontaneous regression of granulomatous mycosis fungoides in an HIV positive patient
14. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor Vβ gene expansion